Is There Already a Need of Reckoning on Cancer Immunotherapy?
Pierpaolo Correale, Francesca Pentimalli, Giovanni Baglio et al. · Frontiers in Pharmacology · 2021
Abstract onlyNot checked
Medicine: papers
Filters1 filter applied
Status
- Corrected
- No notice
- Not checked
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
Italian guidelines for the diagnosis and treatment of Paget’s disease of bone
G.C. Isaia, G. Bianchi, S. Gonnelli et al. · Reumatismo · 2011
Abstract onlyNot checked
Radiotherapy combined with PD‐1/PD‐L1 inhibitors in NSCLC brain metastases treatment: The mechanisms, advances, opportunities, and challenges
Zi‐Ying Chen, Xiao‐Tong Duan, Si‐Miao Qiao et al. · Cancer Medicine · 2023
Abstract onlyNot checked
Future perspectives in melanoma research
Paolo A. Ascierto, Sanjiv Agarwala, Gerardo Botti et al. · Journal of Translational Medicine · 2016
Abstract onlyNot checked
Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response
Elaine R. Mardis · Genome Medicine · 2019
Abstract onlyNot checked
Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review
Keisuke Onoi, Yusuke Chihara, Junji Uchino et al. · Journal of Clinical Medicine · 2020 · Review
Full textCC BY
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
Alexandre Reuben, Christine N. Spencer, Peter A. Prieto et al. · npj Genomic Medicine · 2017
Full textCC BY
A short review: Characterization and Heath Effects of Saffron Utilizing in Disease Treatment and Prevention
Thi Sinh Vo, Tran Thi Bich Chau Vo, Tran Thi Thu Ngoc Vo · Journal of Research in Clinical Medicine · 2021
Abstract onlyNot checked
Epidemiological Profiles and Clinical Outcomes of Non-COVID-19 Patients during COVID-19 Pandemic: A Single-Center Experience
Yousef M Alsofayan, Trad S Alwakeel, Hebah A Alnasser et al. · Journal of Nature and Science of Medicine · 2022
Abstract onlyNot checked
Rehabilitation in patients with lymphoma: An overview of Systematic Reviews
Bhasker Amatya, Fary Khan, Thomas E. Lew et al. · Journal of Rehabilitation Medicine · 2021
Abstract onlyNot checked
Gynecomastia: A systematic review of pharmacological treatments
Ori Berger, Zohar Landau, Zohar Landau et al. · Frontiers in Pediatrics · 2022
Abstract onlyNot checked
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
Julian Musa, Florencia Cidre-Aranaz, Marie-Ming Aynaud et al. · Nature Communications · 2019
Abstract onlyNot checked
Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer
Wen-Qian Li, Ling-Yu Li, Ri-Lan Bai et al. · Chinese Medical Journal · 2020
Abstract onlyNot checked
Existing Health Practices in Shaping the Decision to Participate During Breast Cancer Screening Among 50–69 Years Old Women in Estonia
Kadi Lubi PhD, Kaire Sildver RM, RN, MSc, Diana Sokolova RM, RN et al. · SAGE Open Nursing · 2022
Abstract onlyNot checked
Cell Fusion-Related Proteins and Signaling Pathways, and Their Roles in the Development and Progression of Cancer
Hao Zhang, Hong Ma, Xiaohui Yang et al. · Frontiers in Cell and Developmental Biology · 2022
Abstract onlyNot checked
Update on Poly ADP-Ribose Polymerase Inhibitors in Ovarian Cancer With Non-BRCA Mutations
Qin Xu, Zhengyu Li · Frontiers in Pharmacology · 2021
Abstract onlyNot checked
Impact of Ninjin'Yoeito on Fatigue in Patients Receiving Nab-Paclitaxel Plus Gemcitabine Therapy: A Prospective, Single-Arm, Phase II Open Label, Nonrandomized, Historically-Controlled Study
Ken-ichi Okada, MD, PhD, Manabu Kawai, MD, PhD, Seiko Hirono, MD, PhD et al. · Current Therapeutic Research · 2020
Abstract onlyNot checked
Multiple oncogenic viruses are present in human breast tissues before development of virus associated breast cancer
James S. Lawson, Wendy K. Glenn · Infectious Agents and Cancer · 2017
Abstract onlyNot checked
Corrigendum
Therapeutic Advances in Medical Oncology · 2013
Abstract onlyNot checked
Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway
Xiangjin Zheng, Wan Li, Huanli Xu et al. · Acta Pharmaceutica Sinica B · 2021
Abstract onlyNot checked